Bain Capital Life Sciences Investors, LLC Buys Rapid Micro Biosystems Inc, Adagio Therapeutics Inc, Nuvalent Inc, Sells Atea Pharmaceuticals Inc, Dynavax Technologies Corp, Kymera Therapeutics Inc

• New Purchases: RPID, ADGI, NUVL, TNGX, ARYE,
• Added Positions: AGLE,
• Reduced Positions: SWTX, AVIR, DVAX,
• Sold Out: KYMR, BCTG,

For the details of Bain Capital Life Sciences Investors, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/bain+capital+life+sciences+investors%2C+llc/current-portfolio/portfolio

1. SpringWorks Therapeutics Inc (SWTX) - 4,831,307 shares, 19.01% of the total portfolio. Shares reduced by 17.15%
2. Dynavax Technologies Corp (DVAX) - 8,415,000 shares, 10.03% of the total portfolio. Shares reduced by 28.52%
3. Rapid Micro Biosystems Inc (RPID) - 8,434,560 shares, 9.66% of the total portfolio. New Position
4. Atea Pharmaceuticals Inc (AVIR) - 3,700,000 shares, 8.05% of the total portfolio. Shares reduced by 34.11%
5. Adagio Therapeutics Inc (ADGI) - 2,487,207 shares, 6.52% of the total portfolio. New Position

Bain Capital Life Sciences Investors, LLC initiated holding in Rapid Micro Biosystems Inc. The purchase prices were between $17.88 and $24.8, with an estimated average price of $20.63. The stock is now traded at around $16.085000. The impact to a portfolio due to this purchase was 9.66%. The holding were 8,434,560 shares as of 2021-09-30.

Bain Capital Life Sciences Investors, LLC initiated holding in Adagio Therapeutics Inc. The purchase prices were between $20.88 and $56.08, with an estimated average price of $37.24. The stock is now traded at around $19.795000. The impact to a portfolio due to this purchase was 6.52%. The holding were 2,487,207 shares as of 2021-09-30.

Bain Capital Life Sciences Investors, LLC initiated holding in Nuvalent Inc. The purchase prices were between $18.25 and $38.35, with an estimated average price of $29.21. The stock is now traded at around $24.830000. The impact to a portfolio due to this purchase was 4.8%. The holding were 3,428,014 shares as of 2021-09-30.

Bain Capital Life Sciences Investors, LLC initiated holding in Tango Therapeutics Inc. The purchase prices were between $9.56 and $17.3, with an estimated average price of $13.13. The stock is now traded at around $13.665000. The impact to a portfolio due to this purchase was 1.54%. The holding were 1,921,790 shares as of 2021-09-30.

Bain Capital Life Sciences Investors, LLC initiated holding in ARYA Sciences Acquisition Corp V. The purchase prices were between $9.8 and $10.08, with an estimated average price of $9.92. The stock is now traded at around $9.900000. The impact to a portfolio due to this purchase was 0.31%. The holding were 500,000 shares as of 2021-09-30.

Bain Capital Life Sciences Investors, LLC sold out a holding in Kymera Therapeutics Inc. The sale prices were between $47.8 and $66.66, with an estimated average price of $57.98.

Bain Capital Life Sciences Investors, LLC sold out a holding in BCTG Acquisition Corp. The sale prices were between $9.88 and $11.33, with an estimated average price of $10.53.